Kenvue Inc
KVUE17.210USD
0.000
Close 12/26, 16:00（ET）Quotes delayed by 15 min
32.97BMarket Cap
23.02P/E TTM
More Details of Kenvue Inc Company
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Kenvue Inc Info
Ticker SymbolKVUE
Company nameKenvue Inc
IPO dateMay 04, 2023
CEOPerry (Kirk L)
Number of employees22000
Security typeOrdinary Share
Fiscal year-endMay 04
Address1 Kenvue Way
CitySUMMIT
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07901
Phone19088741200
Websitehttps://www.kenvue.com
Ticker SymbolKVUE
IPO dateMay 04, 2023
CEOPerry (Kirk L)
Company Executives of Kenvue Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
66.04K
+2.48%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
58.09K
+3.16%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.88K
+1.70%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
32.65K
+4.11%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
27.59K
+9.30%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
10.79K
-62.07%
Mr. Russell Dyer
Mr. Russell Dyer
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
1.70K
--
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
151.00
-99.15%
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
66.04K
+2.48%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
58.09K
+3.16%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.88K
+1.70%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
32.65K
+4.11%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Face and Body Care
691.02M
18.00%
Other Self Care
614.24M
16.00%
Cough, Cold and Allergy
462.64M
12.05%
Other Essential Health
459.70M
11.97%
Oral Care
459.70M
11.97%
Other
1.15B
30.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Face and Body Care
691.02M
18.00%
Other Self Care
614.24M
16.00%
Cough, Cold and Allergy
462.64M
12.05%
Other Essential Health
459.70M
11.97%
Oral Care
459.70M
11.97%
Other
1.15B
30.00%
Shareholding Stats
Updated: Thu, Dec 18
Updated: Thu, Dec 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.13%
State Street Investment Management (US)
5.99%
T. Rowe Price Associates, Inc.
5.81%
BlackRock Institutional Trust Company, N.A.
5.08%
MFS Investment Management
4.36%
Other
66.62%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.13%
State Street Investment Management (US)
5.99%
T. Rowe Price Associates, Inc.
5.81%
BlackRock Institutional Trust Company, N.A.
5.08%
MFS Investment Management
4.36%
Other
66.62%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.78%
Investment Advisor/Hedge Fund
27.32%
Hedge Fund
9.38%
Research Firm
3.91%
Pension Fund
1.75%
Sovereign Wealth Fund
1.51%
Bank and Trust
1.22%
Individual Investor
1.13%
Family Office
0.19%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2127
1.94B
100.91%
-295.23M
2025Q2
2098
1.93B
100.46%
-321.30M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
232.38M
12.11%
+4.08M
+1.78%
Jun 30, 2025
State Street Investment Management (US)
115.02M
5.99%
-5.25M
-4.36%
Jun 30, 2025
T. Rowe Price Associates, Inc.
164.28M
8.56%
-44.09M
-21.16%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
95.80M
4.99%
+1.47M
+1.56%
Jun 30, 2025
MFS Investment Management
87.63M
4.57%
-5.46M
-5.86%
Jun 30, 2025
Fidelity Management & Research Company LLC
82.90M
4.32%
-9.47M
-10.25%
Jun 30, 2025
Geode Capital Management, L.L.C.
49.00M
2.55%
+604.95K
+1.25%
Jun 30, 2025
American Century Investment Management, Inc.
30.27M
1.58%
+8.44M
+38.65%
Jun 30, 2025
Wellington Management Company, LLP
46.37M
2.42%
-15.10M
-24.56%
Jun 30, 2025
Independent Franchise Partners LLP
31.27M
1.63%
+21.89M
+233.36%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Renaissance IPO ETF
7.13%
American Century Focused Large Cap Value ETF
3.3%
VanEck Morningstar Wide Moat Value ETF
3.29%
ProShares Ultra Consumer Staples
2.91%
TBG Dividend Focus ETF
2.75%
Brookstone Value Stock ETF
2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.13%
MarketDesk Focused US Dividend ETF
1.93%
Consumer Staples Select Sector SPDR Fund
1.84%
VanEck Morningstar Wide Moat ETF
1.76%
View more
Renaissance IPO ETF
Proportion7.13%
American Century Focused Large Cap Value ETF
Proportion3.3%
VanEck Morningstar Wide Moat Value ETF
Proportion3.29%
ProShares Ultra Consumer Staples
Proportion2.91%
TBG Dividend Focus ETF
Proportion2.75%
Brookstone Value Stock ETF
Proportion2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proportion2.13%
MarketDesk Focused US Dividend ETF
Proportion1.93%
Consumer Staples Select Sector SPDR Fund
Proportion1.84%
VanEck Morningstar Wide Moat ETF
Proportion1.76%
Dividend
A total of
2.32B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 29, 2025
KVUE.NB Final Cash Dividend of gross USD 0.2075 paid on Nov 26, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 26, 2025
Nov 12, 2025
Jul 30, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Aug 27, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 27, 2025
Aug 13, 2025
Apr 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on May 28, 2025 going ex on May 14, 2025
May 14, 2025
May 28, 2025
May 14, 2025
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Kenvue Inc?
The top five shareholders of Kenvue Inc are:
The Vanguard Group, Inc. holds 232.38M shares, accounting for 12.11% of the total shares.
State Street Investment Management (US) holds 115.02M shares, accounting for 5.99% of the total shares.
T. Rowe Price Associates, Inc. holds 164.28M shares, accounting for 8.56% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 95.80M shares, accounting for 4.99% of the total shares.
MFS Investment Management holds 87.63M shares, accounting for 4.57% of the total shares.
The Vanguard Group, Inc. holds 232.38M shares, accounting for 12.11% of the total shares.
State Street Investment Management (US) holds 115.02M shares, accounting for 5.99% of the total shares.
T. Rowe Price Associates, Inc. holds 164.28M shares, accounting for 8.56% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 95.80M shares, accounting for 4.99% of the total shares.
MFS Investment Management holds 87.63M shares, accounting for 4.57% of the total shares.
What are the top three shareholder types of Kenvue Inc?
The top three shareholder types of Kenvue Inc are:
The Vanguard Group, Inc.
State Street Investment Management (US)
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
State Street Investment Management (US)
T. Rowe Price Associates, Inc.
How many institutions hold shares of Kenvue Inc (KVUE)?
As of 2025Q3, 2127 institutions hold shares of Kenvue Inc, with a combined market value of approximately 1.94B, accounting for 100.91% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 0.44%.
What is the biggest source of revenue for Kenvue Inc?
In FY2025Q2, the Face and Body Care business generated the highest revenue for Kenvue Inc, amounting to 691.02M and accounting for 18.00% of total revenue.
